Alyeska Investment Group, L.P. Dyne Therapeutics, Inc. Transaction History

Alyeska Investment Group, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$23.65 - $35.63 $591,250 - $890,750	25,000 New	25,000 $882,000
Q1 2021 May 17, 2021	BUY	$14.0 - $29.3 $658,000 - $1.38 Million	47,000 Added 59.82%	125,566 $1.95 Million
Q4 2020 Feb 16, 2021	BUY	$16.81 - $23.94 $829,926 - $1.18 Million	49,371 Added 169.11%	78,566 $1.65 Million
Q3 2020 Nov 16, 2020	BUY	$20.0 - $23.9 $583,900 - $697,760	29,195 New	29,195 $589,000

210

102M

234K

238K

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $1.54B
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.